Lurbinectedin is a drug used to treat certain types of cancer. There is no specific information available about the effects of Lurbinectedin on infants. However, the drug is not recommended for use during pregnancy as it may harm the fetus. Women of childbearing age are advised to use effective birth control during treatment and for at least two months after the last dose of Lurbinectedin [2].
The drug has been associated with several side effects. Some common side effects include fatigue, nausea, vomiting, loss of appetite, constipation, diarrhea, and hair loss. Other serious side effects include low white blood cell count, liver problems, and nerve damage. Patients should seek medical attention immediately if they experience symptoms such as fever, chills, cough, chest pain, shortness of breath, severe abdominal pain, or yellowing of the skin or eyes [2].
Lurbinectedin should only be administered under the supervision of a healthcare professional who is experienced in the use of chemotherapy drugs. The drug may interact with other medications, so patients should inform their doctor of all medications they are taking, including over-the-counter drugs and herbal supplements [3].
In conclusion, while there is no specific information available about the effects of Lurbinectedin on infants, the drug is not recommended for use during pregnancy and women of childbearing age are advised to use effective birth control during treatment. The drug has several side effects, some of which can be serious, and should only be administered under the supervision of a healthcare professional [2][3].
Sources:
[1] DrugPatentWatch. (n.d.). Lurbinectedin. Retrieved from https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] Mayo Clinic. (2021, January 1). Lurbinectedin (Intravenous Route) - Side Effects. Retrieved from https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] iCliniq. (2021, February 8). Lurbinectedin. Retrieved from https://www.icliniq.com/articles/cancer/lurbinectedin